Patient Home Monitoring, Inc.

Presenter: Michael Dalsin, Chairman

Company Information

Company Type: Services

Development Stage: Private

Company Profile

Patient Home Monitoring, Inc. (PHM) provides in-home diagnostic testing and monitoring services to patients and their referring physicians. PHM is currently focused on the four million chronically ill US patients taking blood thinners, such as Coumadin or warfarin that require frequent testing of their blood coagulation levels to ensure safe and effective treatment. In 2009 Medicare decided to pay for in-home diagnostic services to monitor blood coagulation levels for a large percentage of patients taking blood thinners such as Coumadin, where patients previously had to travel to a laboratory for this service and were reimbursed only through private healthcare. Currently, fewer than 100,000 of the four million patients have been enrolled in this new type of service and PHM expects millions of patients will choose the in-home option over the next several years because of improved safety and convenience.
At its core, PHM is a logistics and information company. Medicare or a private health insurance company pays PHM to supply the patient a testing meter and finger prick testing strips. PHM uses a state-of-the-art logistics and patient tracking system to monitor patients and inform cardiologists of their in-home testing results. PHM's competitive advantage is the systematic approach toward enrolling patients managed by large cardiology groups and is the only company in the market focused on approaching these large doctor groups to systematically enroll their patients, instead of approaching the patients directly. These major groups historically have thousands of chronic patients under management, providing PHM with a large patient population in each group.
PHM is listed and in the process of changing its name from International Health Partners to Patient Home Monitoring, Inc (TSX-V:DOC).

Presenter Bio

For the past 8 years, Mr. Dalsin has been a General Partner in Stanmore Capital Partners, an investment fund specializing in US healthcare service companies. Previous to Stanmore, he has served as banking and deal advisor to a number of Sovereign Funds in Europe, Asia and Australia. Mr. Dalsin started his banking career as an international investment banker and deal-maker with investments by Morgan Stanley Managing Directors funds in London, Hong Kong and New York. He participated as a lead banker and negotiator for a number of international acquisitions for US, Asian, European and Asian Sovereign Funds and companies. He was as a key sales person in institutional fundraising for a number of public (micro-capitalization) companies in Europe, the US, and Australia. He has experience in securing debt for small and medium sized companies and has practice in high yield and convertible debt for the purposes of acquisition.

Mr. Dalsin has been invited to speak for Inc. Magazine and Cambridge University in the UK on the topic of deal making in small to medium market acquisitions. Mr. Dalsin both lived and worked in Europe (London, England), South Asia (Hong Kong and Singapore), Australia (Sydney), and South America (Caracas, Venezuela).

Contact

Patient Home Monitoring, Inc.
550 Kearny St., Suite 300
San Francisco
CA, USA
94104

ph: 323-253-3055
fx: 416-815-0080

ww.phmhometesting.com
mpd@stanmorecap.com